Reference
Finazzi T, et al. Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy. BMC Cancer 18: 395, No. 1, 6 Apr 2018. Available from: URL: http://doi.org/10.1186/s12885-018-4295-8 - Switzerland
Rights and permissions
About this article
Cite this article
Amoxicillin/clavulanic-acid/pembrolizumab. Reactions Weekly 1701, 27 (2018). https://doi.org/10.1007/s40278-018-45859-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-45859-6